Conditions: Acute Migraine With or Without Aura in Adolescents
Keywords: acute migraine with or without aura in adolescents
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 674
Healthy volunteers: no

Brief summary:
To provide long term safety data for rizatriptan in children and adolescents. The primary hypothesis of the study is that rizatriptan is well tolerated in the long term treatment of acute migraine in pediatric patients age 12-17 years.

Detailed description:

Arms:
arm 1: Rizatriptan benzoate

Interventions: intervention 1: rizatriptan benzoate
Intervention descriptions: intervention 1: Single dose of 5 mg or 10 mg orally disintegrating tablet at onset of migraine attack

Protocol document: